BeiGene to Present at the J.P. Morgan 39th Annual Healthcare Conference
BeiGene to Present at the J.P. Morgan 39th Annual Healthcare Conference
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that the Company will participate in the J.P. Morgan 39th Annual Healthcare Conference
on Thursday, January 14, 2021 at 5:20 p.m. ET.
A live webcast can be accessed from the investors section of BeiGenes website at https://ir.beigene.com or https://hkexir.beigene.com. An archived replay will be available for 90 days following the event.
About BeiGene